In this study, our data underlined the role of the PNPLA3 GG genotype in association with significant fibrosis, which aligned with previous meta-analysis data indicating an increased risk of this variant on progressive fibrosis in MASLD [21]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.